Position in AIM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$226,207
+$214,380 QoQ
Shares Held
807,885
+3930.0% QoQ
Ownership
2.65%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 16 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AIM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,130,252 across 291 Biotechnology names. AIM ranks #163 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in AIM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $226,207 | 807,885 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $11,827 | 20,047 | Shares | Defined | 2026-05-12 | |
| 2023-12-31 | $9,353 | 21,257 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $6,298 | 13,692 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $14,836 | 22,144 | Shares | Defined | 2023-08-14 | |
| 2022-06-30 | $8,108 | 10,396 | Shares | Defined | 2022-08-16 | |
| 2021-12-31 | $14,259 | 15,499 | Shares | Defined | 2022-02-15 | |
| 2020-03-31 | $71,738 | 28,023 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||